Cravings by myDNAhealth — Ingredients, Evidence & Safety

🟢 100/100

This product looks safe

No ingredients exceed tolerable upper intake levels
70% of ingredients have research evidence

A Label Compliance Grade

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Capsule(s) Serving Size

Other Combinations Product Type

70% Evidence Coverage

Supplement Facts — Evidence Check

N-Acetyl L-Cysteine

150 mg

L-Tyrosine

150 mg

📊 Market median: 500.0mg (223 products) 📚 22 studies (Tier A: 0, B: 1)

This product: 150mg

S-Adenosyl Methionine

150 mg

📊 Market median: 200.0mg (52 products) 📚 10 studies (Tier A: 0, B: 6)

This product: 150mg

Magnesium Glycinate

10 mg

📊 Market median: 220.0mg (190 products)

RDA 420mg This product: 10mg UL 350mg

Alpha Lipoic Acid

50 mg

📊 Market median: 200.0mg (198 products) 📚 6 studies — no high-quality reviews

This product: 50mg

Vitamin B6

25 mg

📊 19.2× RDA — above typical dose (UL: 100 mg) 📚 113 studies (Tier A: 3, B: 35)

RDA 1.3mg This product: 25mg UL 100mg

Co-Enzyme Q10

30 mg

📊 Market median: 100.0mg (283 products) 📚 142 studies (Tier A: 1, B: 64)

This product: 30mg UL 1200mg

5-HTP

50 mg

📊 Market median: 100.0mg (116 products) 📚 15 studies (Tier A: 0, B: 3)

This product: 50mg

Siberian Ginseng

75 mg

📊 Market median: 450.0mg (390 products) 📚 155 studies (Tier A: 0, B: 63)

This product: 75mg

Chromium Picolinate

200 mcg

📊 5.7× RDA — above typical dose 📚 197 studies (Tier A: 1, B: 55)

RDA 0.035mg This product: 0.2mg

Label Claims — Verification

❓ Nutrient

❓ All Other

❓ Structure/Function

All Other (100% of products) Structure/Function (83% of products) Nutrient (6% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Directions Take two capsules before lunch or dinner to reduce cravings over the following four hours, or as directed by your healthcare practitioner.

⚠️ Warnings & Precautions

Caution Do not exceed recommended dose.

Keep out of reach of children.

Do not take if you have high blood pressure, prone to seizures, have a bleeding disorder or liver disease.

Consult your medical practitioner before taking these capsules if you are on medication. It is not recommended that children, pregnant or nursing women take this supplement.

It is not recommended that children, pregnant or nursing women take this supplement.

Stop taking if any side-effects occur.

🧪 Formulation Notes

Does not contain gluten, dairy or GMO.

Contains starch.

Additional Information

Intelligent health and nutrition

Reduces cravings

For weight management

Description Cravings is a natural supplement to assist with reducing cravings and improve wellbeing. Cravings helps to stabilise blood sugar levels.

Manufactured in the United Kingdom to GMP code of practice and BS:EN 9001:2000 Quality Assured Certification

Product Details

UPC / SKU 0 700461 233336

DSLD Entry Date 2019-02-25

Product Type Other Combinations

Form Capsule

Brand myDNAhealth

DSLD ID 199642

Data Updated 2026-04-11

Research Evidence

12 Research Sources

58 Avg Quality Score

8 Meta Analysis

3 Systematic Review

1 Rct

B S-adenosyl-L-methionine for alcoholic liver diseases

Meta Analysis The Cochrane database of systematic reviews 2006

PubMed

B S-adenosyl methionine (SAMe) for depression in adults

Meta Analysis The Cochrane database of systematic reviews 2016

PubMed

B Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR/PReS recommendations for the diagnosis and management of Still's disease

Meta Analysis Annals of the rheumatic diseases 2024

PubMed DOI

B SAMe-TT2R2 Score to Predict Time in Therapeutic Range of Vitamin K Antagonists in Asian and Non-Asian patients: A Systematic Review and Meta-analysis

Meta Analysis American journal of cardiovascular drugs : drugs, devices, and other interventions 2024

PubMed DOI

B S-Adenosylmethionine (SAMe) as an adjuvant therapy for patients with depression: An updated systematic review and meta-analysis

Meta Analysis General hospital psychiatry 2024

PubMed DOI

B S-adenosyl-L-methionine for alcoholic liver diseases

Systematic Review The Cochrane database of systematic reviews 2001

PubMed

B WITHDRAWN: S-adenosyl-L-methionine for alcoholic liver diseases

Meta Analysis The Cochrane database of systematic reviews 2015

PubMed DOI

C S-adenosyl-L-methionine for the treatment of chronic liver disease: a systematic review and meta-analysis